Champions Oncology, Inc. (CSBR)

4.99 +0.02 (+0.40%) USD  |  NASDAQ  |  Aug 25, 16:00
4.99 0.00 (0.00%) After-Hours: 16:51
More

Champions Oncology Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for CSBR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
December 16, 2025 --
September 16, 2025 --
July 24, 2025 --
March 12, 2025 --
December 12, 2024 --
September 12, 2024 --
July 19, 2024 --
Date Value
March 13, 2024 --
December 13, 2023 --
September 22, 2023 --
September 14, 2023 --
July 26, 2023 --
July 25, 2023 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Medpace Holdings, Inc. Upgrade
Avantor, Inc. Upgrade
Personalis, Inc. Upgrade
Adaptive Biotechnologies Corp. Upgrade
10X Genomics, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade